Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
- 7 April 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (14) , 5960-5965
- https://doi.org/10.1073/pnas.0900808106
Abstract
Natural resistance-associated macrophage protein 1 (Nramp1) is a divalent metal transporter expressed exclusively in phagocytic cells. We hypothesized that macrophage Nramp1 may participate in the recycling of iron acquired from phagocytosed senescent erythrocytes. To evaluate the role of Nramp1 in vivo, the iron parameters of WT and KO mice were analyzed after acute and chronic induction of hemolytic anemia. We found that untreated KO mice exhibited greater serum transferrin saturation and splenic iron content with higher duodenal ferroportin (Fpn) and divalent metal transporter 1 (DMT1) expression. Furthermore, hepatocyte iron content and hepcidin mRNA levels were dramatically lower in KO mice, indicating that hepcidin levels can be regulated by low-hepatocyte iron stores despite increased transferrin saturation. After acute treatment with the hemolytic agent phenylhydrazine (Phz), KO mice experienced a significant decrease in transferrin saturation and hematocrit, whereas WT mice were relatively unaffected. After a month-long Phz regimen, KO mice retained markedly increased quantities of iron within the liver and spleen and exhibited more pronounced splenomegaly and reticulocytosis than WT mice. After injection of (59)Fe-labeled heat-damaged reticulocytes, KO animals accumulated erythrophagocytosed (59)Fe within their liver and spleen, whereas WT animals efficiently recycled phagocytosed (59)Fe to the marrow and erythrocytes. These data imply that without Nramp1, iron accumulates within the liver and spleen during erythrophagocytosis and hemolytic anemia, supporting our hypothesis that Nramp1 promotes efficient hemoglobin iron recycling in macrophages. Our observations suggest that mutations in Nramp1 could result in a novel form of human hereditary iron overload.Keywords
This publication has 67 references indexed in Scilit:
- Clinical, pathological, and molecular correlates in ferroportin disease: A study of two novel mutationsJournal of Hepatology, 2008
- The Serine Protease TMPRSS6 Is Required to Sense Iron DeficiencyScience, 2008
- Nramp1 equips macrophages for efficient iron recyclingExperimental Hematology, 2008
- Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4Blood, 2007
- Suppression of hepcidin during anemia requires erythropoietic activityBlood, 2006
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosisNature Genetics, 2002
- The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammationJournal of Clinical Investigation, 2002
- Erythropoietic precursors in mice with phenylhydrazine‐induced anemiaAmerican Journal of Hematology, 1976